Beyond Meat

BYND · NASDAQ

$6.81+$0.24 (+3.65%)TodayMarket closed · Oct 20, 7:56 PM ET

Prev close $6.57

BYND analyst rating

HoldConsensus of 4 analysts over the last 12 months. 0% rate it a buy.

Strong buy0
Buy0
Hold2
Underperform2
Sell0

12-month price target · 5 analysts

Average $75.51 (+1008.9% upside)

Low: $10.10
Now: $6.81
High: $206.96

Upgrades and downgrades

The latest rating actions, newest first

BYND analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Barclays	Aug 17, 2026	Maintains	Underweight	$0.50 → $10.00	48%
BMO Capital	Apr 6, 2026	Maintains	Market Perform	$4.00 → $1.00	51%
Barclays	Apr 2, 2026	Maintains	Underweight	$1.00 → $0.50	48%
Mizuho	Nov 13, 2025	Maintains	Underperform	$1.50 → $1.00	48%
Barclays	Nov 12, 2025	Maintains	Underweight	$2.00 → $1.00	48%
Mizuho	Oct 24, 2025	Maintains	Underperform	$2.00 → $1.50	48%
BTIG	Oct 24, 2025	Maintains	Neutral	—	53%

The case for and against

Updated Mar 20, 2026

Bull case

Beyond Meat Inc. has positioned itself favorably through its innovative approach to plant-based meats, catering to a growing consumer interest in healthier and environmentally friendly alternatives to traditional meat products. The company is seeing key upside risks, including a potential rebound in retail sales and accelerated partnerships with restaurants, which could bolster revenue across various channels, including grocery and foodservice sectors. Additionally, recent measures to reduce outstanding debt from $1.15 billion to $215 million demonstrate an improved financial foundation, enhancing the company's ability to navigate and capitalize on the evolving market demand for plant-based options.

Bear case

Beyond Meat Inc. is facing significant financial challenges, as evidenced by a gross margin decline from 12.8% to 10.8% primarily due to reduced sales volume and sales deleverage, despite some offset from production efficiency and price increases. Additionally, the company's sales have decreased by 13.2% to $283.5 million, driven by a downturn in the plant-based meat category, consumer down-trading, and inflationary pressures that have negated the effects of price hikes. Furthermore, key downside risks remain, including worsening sales performance due to weaker category growth, brand perceptions, slow adoption rates of plant-based proteins, increased competition, and ongoing cash burn.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.